Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Ugo Testa, Germana Castelli, Elvira Pelosi
Cancers (2018) Vol. 10, Iss. 8, pp. 248-248
Open Access | Times Cited: 324

Showing 1-25 of 324 citing articles:

Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 760
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)
Jingyi He, Zhengrong Huang, Linzhi Han, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 5
Open Access | Times Cited: 200
Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
Masahiro Shibata, Mohammad Obaidul Hoque
Cancers (2019) Vol. 11, Iss. 5, pp. 732-732
Open Access | Times Cited: 195
Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
Kai Fu, Fachao Xie, Fang Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 184
Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
Eric Santoni‐Rugiu, Linea Cecilie Melchior, Edyta Maria Urbanska, et al.
Cancers (2019) Vol. 11, Iss. 7, pp. 923-923
Open Access | Times Cited: 147
Air pollution: A culprit of lung cancer
Yueguang Xue, Liuxiang Wang, Yiming Zhang, et al.
Journal of Hazardous Materials (2022) Vol. 434, pp. 128937-128937
Closed Access | Times Cited: 117
Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing
Peng Song, Wenbin Li, Lei Guo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 84
Machine learning reveals diverse cell death patterns in lung adenocarcinoma prognosis and therapy
Shun Wang, Ruohuang Wang, Dingtao Hu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 35
Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer
Yagmur Azbazdar, Mustafa Karabicici, Esra Erdal, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 70
Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
Qitong Wu, Sumit Siddharth, Dipali Sharma
Cancers (2021) Vol. 13, Iss. 15, pp. 3697-3697
Open Access | Times Cited: 66
DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine
Runzhang Liang, Xiaosong Li, Weiquan Li, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112202-112202
Open Access | Times Cited: 59
Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy
Hend M. Nawara, Said M. Afify, Ghmkin Hassan, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 500-500
Open Access | Times Cited: 58
A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability
Juhong Wang, Fei Shao, Yannan Yang, et al.
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 1008-1027
Open Access | Times Cited: 42
Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma
Peng Song, Wenbin Li, Xiaoxuan Wu, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2341-2354
Closed Access | Times Cited: 41
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics
Emanuele Barabino, Giovanni Rossi, Silvia Pamparino, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 350-350
Open Access | Times Cited: 39
Biological and Genetic Mechanisms of COPD, Its Diagnosis, Treatment, and Relationship with Lung Cancer
Karolina H. Czarnecka, Debjita Mukherjee, Sofya V. Maryanchik, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 448-448
Open Access | Times Cited: 27
Whole‑exome sequencing reveals Lewis lung carcinoma is a hypermutated Kras/Nras–mutant cancer with extensive regional mutation clusters in its genome
Quan He, Cuirong Sun, Yuan-Jiang Pan
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Advancing cancer theranostics through biomimetics: A comprehensive review
Kuttiappan Anitha, Santenna Chenchula, Vijayaraj Surendran, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27692-e27692
Open Access | Times Cited: 10
Single-cell RNA sequencing integrated with bulk RNA sequencing analysis identifies a tumor immune microenvironment-related lncRNA signature in lung adenocarcinoma
Yuqing Ren, Ruhao Wu, Chunwei Li, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Cuproptosis in lung cancer: therapeutic options and prognostic models
Rohil Jawed, Huma Aslam Bhatti
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1393-1398
Closed Access | Times Cited: 8
An acquired CCDC6:: RET gene fusion as resistance mechanism for Osimertinib in exon 21 EGFR(L858R) -mutated non-small cell lung cancer and its successful management with Osimertinib and Selpercatinib: a case report and review of literature
Maud Lormans, Peter Van Haecke, Ingel Demedts
Journal of Chemotherapy (2025), pp. 1-6
Closed Access | Times Cited: 1
Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD4+ T cell induced-type I inflammation
Jing Liu, Tianxiang Li, Hui Wu, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 112, pp. 108580-108580
Open Access | Times Cited: 73
Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases
Jing Zhao, Chao Guo, Zhiming Ma, et al.
Lung Cancer (2020) Vol. 149, pp. 90-96
Closed Access | Times Cited: 56
Role of sex hormones in lung cancer
Nathalie Fuentes, Miguel Silva Rodriguez, Patricia Silveyra
Experimental Biology and Medicine (2021) Vol. 246, Iss. 19, pp. 2098-2110
Open Access | Times Cited: 50
Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations
Hidetoshi Hayashi, Ernest Nadal, Jhanelle E. Gray, et al.
Clinical Lung Cancer (2021) Vol. 23, Iss. 1, pp. e69-e82
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top